Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 5/20 | 0.76 |
| ▸ | GNB1 | P62873 | 5/20 | 0.76 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.63 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | HPGDS | O60760 | 1/20 | 0.59 |
| ▸ | APEX1 | P27695 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | NSD2 | O96028 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18867033 | 0.89 | P2RY12 (0.61) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL18867032 | 0.89 | GNG2 (0.71) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL13214102 | 0.88 | GNG2 (0.73) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL8643316 | 0.88 | GNG2 (0.61) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL14642058 | 0.88 | GNG2 (0.66) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL11425002 | 0.87 | GNG2 (0.68) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL3032353 | 0.87 | GNG2 (0.71) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL10609900 | 0.87 | GNG2 (0.71) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL2778161 | 0.86 | GNG2 (1.00) | GNG2GNB1P2RY12CYP1A2CYP2C9 | |
| SCHEMBL29354288 | 0.86 | GNG2 (1.00) | GNG2GNB1P2RY12CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0099859-B1 | PROCESS FOR DYEING DIFFERENTIAL-DYEING FIBRES | CIBA-GEIGY AG (CH) | 1987-04-01 | — | — | EP | claimed |
| EP-3102637-B1 | METHOD FOR PURIFICATION OF ANTIBODIES, ANTIBODY FRAGMENTS OR ENGINEERED VARIANTS THEREOF USING SPECIFIC ANTHRAQUINONE DYE-LIGAND STRUCTURES | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| EP-2129653-B1 | NOVEL P2Y12 RECEPTOR ANTAGONISTS | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-9512315-B2 | Quenching dye for labeling biomolecules and method for preparing the same | DKC CORPORATION (KR) | 2016-12-06 | — | — | US | disclosed |
| US-9512315-B2 | Quenching dye for labeling biomolecules and method for preparing the same | DKC CORPORATION (KR) | 2016-12-06 | — | — | US | disclosed |
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20160266130-A1 | QUENCHING DYE FOR LABELING BIOMOLECULES AND METHOD FOR PREPARING THE SAME | DKC CORPORATION (KR) | 2016-09-15 | — | — | US | disclosed |
| US-20160266130-A1 | QUENCHING DYE FOR LABELING BIOMOLECULES AND METHOD FOR PREPARING THE SAME | DKC CORPORATION (KR) | 2016-09-15 | — | — | US | disclosed |
| EP-2918641-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2015-09-16 | — | — | EP | disclosed |
| EP-0028203-A1 | Process for carrying off the reaction heat from exothermal chemical reactions and apparatus for carrying out the process | CIBA-GEIGY AG (CH) | 1981-05-06 | — | — | EP | disclosed |
| US-4263206-A | Reactive dyestuffs containing chlorine or fluorine substituents and one or more 1,3-dicyanobenzene radicals linked to the dyestuff at the 2-, 4- or 6-position | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-04-21 | — | — | US | disclosed |
| EP-0024668-A2 | Reactive dyestuffs and their use in dyeing and printing hydroxyl groups and nitrogen containing materials | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
| US-4255325-A | AZO, ANTHRAQUINONE, FORMAZANE, AND PHTHALOCYANINE DYES; COLOR AND WASHFASTNESS; AMINO HALO TRIAZINE CARBAZIDE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
| US-4242259-A | TRIAZINE DYES, COTTON | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| EP-0013765-A1 | Reactive azodyestuffs, their preparation and their use for dyeing materials containing hydroxyl or amide groups | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4213899-A | FOR CELLULOSE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-07-22 | — | — | US | disclosed |
| US-4065446-A | Reactive dyestuffs containing urea alkylene linkage between chromophore and reactive radical | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4001205-A | WATER-SOLUBLE, FIBER-REACTIVE PHENYLAZODIHYDROXY, METHYL, CYANOPYRIDINE DYESTUFFS | CIBA-GEIGY AG (CH) | 1977-01-04 | — | — | US | disclosed |
| US-3956263-A | 4-Methyl-2,6-dihydroxy-3-cyanopyridine containing dyestuffs | CIBA-GEIGY AG (CH) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | ANTXR2, FCGR3B, IGLV6-57 | GNG2 215/4885GNB1 305/4885P2RY12 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.